SCHEMBL4131867

SCHEMBL4131867

CCNC(=O)N(c1cccc(-c2csc3c(OCC(=O)OCC)c(C(=O)OC)sc23)c1)C1CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
MAPT P10636 2/20 0.34
LMNA P02545 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE7A Q13946 1/20 0.34
QPCT Q16769 7/20 0.33
PDE2A O00408 1/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
P2RY12 Q9H244 1/20 0.33
NR1H4 Q96RI1 1/20 0.31
ESR1 P03372 1/20 0.31
PTPN1 P18031 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.31
F9 P00740 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4127835 0.92 ALDH1A1 (0.36) ALDH1A1MAPTLMNASMN1; SMN2NPSR1
SCHEMBL4139259 0.89 POLB (0.36) ALDH1A1MAPTLMNASMN1; SMN2NPSR1
SCHEMBL3192840 0.82 QPCT (0.36) ALDH1A1QPCTPTPN1F9
SCHEMBL4141672 0.81 PTPN1 (0.49) ALDH1A1MAPTLMNASMN1; SMN2NPSR1
SCHEMBL3192856 0.79 PDE2A (0.34) ALDH1A1QPCTPDE2APDE3BPDE3A
SCHEMBL4127833 0.79 MGLL (0.49) ALDH1A1MAPTLMNASMN1; SMN2NPSR1
SCHEMBL4121435 0.77 PTPN1 (0.44) PTPN1
SCHEMBL4131939 0.77 HSD17B10 (0.41) ALDH1A1MAPTLMNASMN1; SMN2PTPN1
SCHEMBL4124234 0.77 PTPN1 (0.42) PTPN1
SCHEMBL4125985 0.75 PTPN1 (0.41) ALDH1A1MAPTLMNASMN1; SMN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048286-A1 Inhibitors of Protein Tyrosine Phosphatase 1B WYETH (US) 2009-02-19 US disclosed
US-20050203081-A1 Inhibitors of protein tyrosine phosphatase 1B WYETH 2005-09-15 US disclosed
WO-2005081960-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B WYETH (US) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203081-A1 Inhibitors of protein tyrosine phosphatase 1B PTPRS, PTPRO, PTPRM ALDH1A1 2329/4885MAPT 3303/4885LMNA 4856/4885
US-20090048286-A1 Inhibitors of Protein Tyrosine Phosphatase 1B PTPRS, PTPRO, PTPRM ALDH1A1 2329/4885MAPT 3303/4885LMNA 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.